LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 1,437 pages found matching black box- "Levaquin Ruined My Life"
Jun-12-09 Washington, DC His name is John Fratti and he walks with a cane. He can barely make it down the stairs. Lest you think that John is a stooped, elderly gentleman, John Fratti is a young man. There's a video of him floating around somewhere of an extremely athletic man shooting hoops with friends. No more. John Fratti's life, he says, has been forever change... - Risks of Oral Sodium Phosphates Known Long Before Health Warning
Apr-30-09 Washington, DC In December of last year the US Food and Drug Administration (FDA) issued a black box warning for Oral Sodium Phosphate (OSP) over concern for kidney failure. However the warning came nearly three years after the FDA first issued a health alert about OSP, and allegedly 9 years after the agency was first alerted to the possibility. Anyo... - Levaquin: The Devil in the Details
Apr-11-09 Washington, DC There is little argument that the Levaquin antibiotic is a good one in terms of its capacity to control and eradicate serious infections. Indeed, Levaquin medicine is powerful stuff. But as is the case with many medicines, the side effects can be worse than the cure and in the case of Levaquin side effects the impact on a patient's phy... - Raptiva: An Itch That Can Kill
Feb-21-09 Washington, DC The road for a drug aimed at the treatment of psoriasis got a little rockier on Thursday after it was revealed the US Food and Drug Administration (FDA) has put Raptiva under the microscope after the drug was potentially linked to 3 deaths . In 2008 a black box warning was ordered. Two days ago the FDA revealed in a statement, "appropriat... - $128,500 payout in racial harassment lawsuit.
Mentor, OH: (Dec-11-07) The city of Mentor brought charges against Michael McDonald, a 16-year-old Mentor boy, after he was found to have left a racist note at the home of a black family. The charges stemmed from McDonald leaving a box marked with the letters "KKK" in the driveway of Sylvia Spikes, who had just moved into the predominantly white neighborho... - Hair Straightener Cancer Legal News and Lawsuit Information
Recent studies have found that hair straighteners and hair relaxers contain toxic chemicals that are known to cause cancer. Increasingly, women who frequently used these products and have been diagnosed with uterine cancer or breast cancer are filing hair straightener cancer lawsuits against L’Oreal, Revlon, and other manufacturers. As well, women who... - How Long to Heal after taking Levaquin?
Nov-6-08 Mount Vernon IL: Jackie W. had bladder surgery 6 years ago and her doctor prescribed Levaquin , a strong antibiotic, to prevent any infection. She has been suffering ever since; not from an infection but a painful shoulder separation, also known as Acromioclavicular (AC) joint sprain. "Just two days after I was on Levaquin I couldn't move my left arm... - Microsoft antitrust Settlement
The antitrust settlement between Microsoft and the Computer and Communications Industry Association resulted in a $9.75M payment to the CCIA top official. Ed Black, CCIA president, received almost half of the $19.75M payment. Ed Black's payment was approved by the CCIA board, which includes Sun Microsystems, Yahoo and Oracle. The CCIA board agreed the one... - Levaquin: Potential Tendon Problems a Serious Limitation
Aug-20-08 Titusville, NJ The problem with a drug prescribed for one malady, yet having a serious side effect impacting a totally different part of the body, is the surprise with which the occurrence often happens. Such is the case with Levaquin , an antibiotic used to treat infections—and its relationship to tendonitis and ruptured tendons . So what's the bi... - Levaquin Upgraded to Black Box Warning
Jul-12-08 Washington, DC On July 8, 2008 the FDA announced that Levaquin will get a black box warning on all fluoroquinolone antibiotics because of an increased risk for tendonitis and tendon rupture. The consumer group Public Citizen first petitioned the agency and then sued to get the warning issued. Levaquin (also known as levofloxacin) is a synthetic antib... - Lawsuit Against GSK Alleges Avandia To Blame For Injury Requiring Heart Bypass Surgery
Feb-13-08 Philadelphia, PA: Pat Kelly and his wife Sandra Kelly of Grove, Oklahoma, filed a lawsuit on February 12, 2008, against Philadelphia-based GlaxoSmithKline ("GSK"), the maker of Avandia , in the U.S. District Court for the Eastern District of Pennsylvania - Case 2:08-cv-00667-RK, accusing GSK of causing serious injury to Mr. Kelly due to its negligence, fr... - Lawmakers Catch Glaxo Hiding Paxil Suicide Risks - Again (Part II)
Feb-13-08 Washington, DC Apparently, GlaxoSmithKline is still trying to hide damaging information about Paxil, because 9 pages of a report released from under a court order last month, are not available to the public. However, Senator Charles Grassley has instructed Glaxo to provide him with the full report by February 14, 2008. In the report, which is dated roug... - Nurse's Family Files Avandia Wrongful Death Lawsuit against GlaxoSmithKline
Dec-18-07 San Diego, CA Rogelio Larosa and his adult son, Eric, of National City, San Diego County, California, filed a lawsuit on Monday, December 17, 2007, against Philadelphia-based GlaxoSmithKline ("GSK"), the maker of Avandia (rosiglitazone maleate), in U.S. District Court, Southern District of California (San Diego) accusing GSK of causing the wrongful death o... - Avandia: Yet Another Nail in the Coffin
Dec-12-07 Toronto, ON: A Canadian study, released yesterday, suggests that for every 100 people taking diabetes drug Avandia over a four-year period—five will die, four will suffer a heart attack and three more will experience heart failure. In response, the US Food and Drug Administration (FDA) is standing pat. The study, originating at the Institute for... - Avandia Dumped From Two Major Formularies
Dec-10-07 Eagan, MN A further sign that a diabetes drug linked to heart attack and heart failure is in trouble, was the news yesterday that two major drug benefit plans in the US have pulled Avandia from their formularies. Scores of physicians have recalled their patients from Avandia in recent months, and sales have been plummeting. Prime Therapeutics, whi... - Glaxo now faces Lawsuit by Shareholders over Avandia Problems
Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of... - Fireworks on Capitol Hill: FDA on the Defensive, Avandia Warnings Toughened
Jun-7-07 Washington, DC In an obvious attempt to save face, the U.S. Food and Drug Administration (FDA) yesterday announced severely toughened black box warnings for Avandia , and Actos - two diabetes drugs strongly suspected of increasing the risk of heart attack. In front of a packed Congressional hearing yesterday called to investigate the long delays by reg... - Doctors Ignore Black Box Warnings On SSRIs
Apr-2-07 Washington, DC: The FDA has issued numerous public health advisories and black box warnings over the past several years about the increased risk of suicidality associated with selective serotonin reuptake inhibitor antidepressants, but many doctors ignore them. In October 2004, the FDA added a black box warning about an increased risk of suicidality i... - FDA Strengthens Warnings on Xolair
Mar-2-07 Seattle, WA: The U.S. Food and Drug Administration (FDA) has called for a black box warning label for Xolair after receiving reports of serious allergic reactions to the drug. The alert was given after the FDA learned of 48 instances of anaphylactic shock that occurred between June, 2003 and December, 2005. Xolair was approved by the FDA for use in 20... - Novartis failed to Warn about Elidel Cancer Link
Dec-28-06 Washington, DC: Most lawsuits in which drug makers have tried to use preemption to dismiss failure-to-warn claims have been against companies accused of failing to warn about the risk of suicide associated with antidepressants known as selective serotonin inhibitors or SSRIs. However, a case in Pennsylvania against Novartis, involves a toddler who devel...